Neuropathological and behavioral consequences of adeno-associated viral vector-mediated continuous intrastriatal neurotrophin delivery in a focal ischemia model in rats

Neurobiology of Disease

Volumn 9, Issue 2, 2002, Pages 187-204

  Andsberg, Gunnar ^a   Kokaia, Zaal ^a   Klein, Ronald L ^b   Muzyczka, Nicholas ^b   Lindvall, Olle ^a   Mandel, Ronald J ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Behavior; Ischemia; Nerve growth factors; Striatum; Stroke; Viral vector

Indexed keywords

ADENOVIRUS VECTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIN; PARVALBUMIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CELL SURVIVAL; CONTROLLED STUDY; CORPUS STRIATUM; GENE TARGETING; GENE TRANSFER; INTERNEURON; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR DYSFUNCTION; NERVE PROJECTION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOMETRY; STRIATE CORTEX; STROKE; TREATMENT OUTCOME; VIRAL GENE DELIVERY SYSTEM;

EID: 0036199880     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2001.0456     Document Type: Article

References (81)

1. Protective effects of neurotrophin-4/5 and transforming growth factor-alpha on striatal neuronal phenotypic degeneration after excitotoxic lesioning with quinolinic acid
2. Anterograde transport of brain-derived neurotrophic factor and its role in the brain
3. Amelioration of ischaemia-induced neuronal death in the rat striatum by NGF-secreting neural stem cells
4. An alternative method for the quantitation of neuronal damage after experimental middle cerebral artery occlusion in rats: Analysis of behavioral deficit
5. Brain-derived neurotrophic factor protects against ischemic cell damage in rat hippocampus
6. Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurologic examination
7. Locomotor and passive avoidance deficits following occlusion of the middle cerebral artery
8. Early assessment of motor dysfunctions aids in successful occlusion of the middle cerebral artery
9. Elevated body swing test: A new behavioral parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism
10. Marked age-dependent neuroprotection by brain-derived neurotrophic factor against neonatal hypoxic-ischemic brain injury
11. Ischemic damage in the striatum of adult gerbils: Relative sparing of somatostatinergic and cholinergic interneurons contrasts with loss of efferent neurons
12. Compartmental expression of trkB receptor protein in the developing striatum
13. Regulation of neuropeptides in adult rat forebrain by the neurotrophins BDNF and NGF
14. Photochemical stroke model: Flunarizine prevents sensorimotor deficits after neocortical infarcts in rats
15. Ischemic brain damage in mice after selectively modifying BDNF or NT4 gene expression
16. BDNF up-regulates TrkB protein and prevents the death of CA1 neurons following transient forebrain ischemia
17. Transgenic mice expressing beta-galactosidase in mature neurons under neuron-specific enolase promoter control
18. BDNF down-regulates neurotrophin responsiveness TrkB protein and TrkB mRNA levels in cultured rat hippocampal neurons
19. Effects of BDNF infusion on the regulation of TrkB protein and message in adult rat brain
20. Relative sparing of GABAergic interneurons in the striatum of gerbils with ischemia-induced lesions
21. Striatonigral involvement following transient focal cerebral ischemia in the rats: An immunohistochemical study on a reversible ischemia model
22. Paw-reaching sensorimotor and rotational behavior after brain infarction in rats
23. Reduction of ischemic damage in NGF-transgenic mice: Correlation with enhancement of antioxidant enzyme activities
24. Reduction of cortical infarction and impairment of apoptosis in NGF-transgenic mice subjected to permanent focal ischemia
25. Estimators of the number of objects per area unbiased by edge effects
26. The new stereological tools: Disector fractionator nucleator and point sampled intercepts and their use in pathological research and diagnosis
27. BDNF blocks caspase-3 activation in neonatal hypoxia-ischemia
28. BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway
29. Long-term functional end points following middle cerebral artery occlusion in the rat
30. Neurotrophin signal transduction in the nervous system
31. Striatal interneurones: Chemical physiological and morphological characterization
32. Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: Intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system
33. Long-term actions of vector-derived nerve growth factor or brain-derived neurotrophic factor on choline acetyltransferase and Trk receptor levels in the adult rat basal forebrain
34. Intraparenchymal NGF injections in adult and aged rats induce long-lasting Trk tyrosine phosphorylation
35. Experimental studies of ischemic brain edema. 1. A new experimental model of cerebral embolism in rats in wich recirculation can be introduced in the ischemic area
36. Focal cerebral ischemia in rats induces expression of p75 neurotrophin receptor in resistant striatal cholinergic neurons
37. Rapid alterations of BDNF protein levels in the rat brain after focal ischemia: Evidence for increased synthesis and anterograde axonal transport
38. Cellular delivery of trophic factors for the treatment of Huntington's disease: Is neuroprotection possible?
39. Evidence for neuroprotective effects of endogenous brain-derived neurotrophic factor after global forebrain ischemia in rats
40. Long-term restoration of striatal L-aromatic amino acid decarboxylase activity using recombinant adeno-associated viral vector gene transfer in a rodent model of Parkinson's disease
41. Neurotrophins and brain insults
42. Intracerebral gene transfer using viral vectors
43. Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease
44. Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats
45. Sensorimotor and cognitive consequences of middle cerebral artery occlusion in rats
46. Recovery of sensorimotor function after distal middle cerebral artery photothrombotic occlusion in rats
47. Ex vivo nerve growth factor gene transfer to the basal forebrain in presymptomatic middle-aged rats prevents the development of cholinergic neuron atrophy and cognitive impairment during aging
48. Penumbral tissues salvaged by reperfusion following middle cerebral artery occlusion in rats
49. Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system
50. Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons
51. The "staircase test": A measure of independent forelimb reaching and grasping abilities in rats
52. NeuN a neuronal specific nuclear protein in vertebrates
53. Use of adeno-associated virus as a general transduction vector for mammalian cells
54. Forelimb akinesia in the rat Parkinson model: Differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test
55. Selective neuronal vulnerability: Morphological and molecular characteristics
56. Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat
57. Adeno-associated viral vectors
58. Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia
59. Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats
60. Rescuing neurons from transsynaptic degeneration after brain damage: Helpful harmful or neutral in recovery of function?
61. A clinically relevant unilateral rat model of Parkinsonian akinesia
62. Intervention strategies for degeneration of dopamine neurons in Parkinsonism: Optimizing behavioral assessment of outcome
63. Rotational behaviour in rats with unilateral striatal kainic acid lesions: A behavioural model for studies on intact dopamine receptors
64. TrkA-immunoreactive profiles in the central nervous system: Colocalization with neurons containing p75 nerve growth factor receptor choline vacetyltransferase and serotonin
65. Viral gene delivery selectively restores feeding and prevents lethality of dopamine-deficient mice
66. Selective sparing of NADPH-diaphorase-somatostatin-neuropeptide Y neurons in ischemic gerbil striatum
67. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system
68. Expression of neurotrophin and trk receptor genes in adult rats with fimbria transections: Effect of intraventricular nerve growth factor and brain-derived neurotrophic factor administration
69. Histochemical mapping of nitric oxide synthase in the rat brain
70. Assessment of sensorimotor neglect after occlusion of the middle cerebral artery in the rat
71. Total number and size distribution of motor neurons in the spinal cord of normal and EMC-virus infected mice - A stereological study
72. Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator
73. The contributions of motor cortex nigrostriatal dopamine and caudate-putamen to skilled forelimb use in the rat
74. Immunocytochemical localization of TrkB in the central nervous system of the adult rat
75. Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system
76. Infarct tolerance induced by intra-cerebral infusion of recombinant brain-derived neurotrophic factor
77. Evaluation of a motor deficit after chronic focal cerebral ischemia in rats
78. The χ-conopeptide SNX-111 an N-type calcium channel blocker dramatically ameliorates brain damage due to transient focal ischaemia
79. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield